An Open-Label, Randomized, Single-Dose, Crossover, Comparative Pharmacokinetics Study of YLB113 and the Etanercept Reference Product in Healthy Adult Male Subjects

被引：0
|
作者：
Mustafa Shennak
Rana Al-Jaouni
Santhosh Kshirasagar
Ravi Sekhar Kasibhatta
Neelima Godse
Ahmad Al-Ghazawi
Praveen Vittala
Dhananjay Bakhle
机构：
[1] Triumpharma,
[2] Lupin Limited,undefined
来源：
European Journal of Drug Metabolism and Pharmacokinetics | 2020年 / 45卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：467 / 475
页数：8
相关论文
共 50 条
  • [21] Single-Dose Comparative Pharmacokinetics of Two Formulations of Lenalidomide 25 mg in Healthy Subjects: A Randomized Crossover Study
    Lee, SeungHwan
    Hwang, Jun Gi
    Park, Sang Yeob
    Lim, Hye Jung
    Lee, Sa-Won
    Seo, Min-Hyo
    Kim, JaeWoo
    Hong, Jang Hee
    ADVANCES IN THERAPY, 2018, 35 (02) : 210 - 217
  • [22] Single-Dose Comparative Pharmacokinetics of Two Formulations of Lenalidomide 25 mg in Healthy Subjects: A Randomized Crossover Study
    SeungHwan Lee
    Jun Gi Hwang
    Sang Yeob Park
    Hye Jung Lim
    Sa-Won Lee
    Min-Hyo Seo
    JaeWoo Kim
    Jang Hee Hong
    Advances in Therapy, 2018, 35 : 210 - 217
  • [23] Pharmacokinetics and bioequivalence of sunitinib and Sutent® in Chinese healthy subjects: an open-label, randomized, crossover study
    Wang, Yanli
    Deng, Qiaohuan
    Gao, Zhenyue
    Liu, Guangwen
    Su, Zhengjie
    Zhao, Yicheng
    Zhang, Lixiu
    Yang, Haimiao
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [24] Comparative Fasting Bioavailability of 2 Bepotastine Formulations in Healthy Male Chinese Volunteers: An Open-Label, Randomized, Single-Dose, 2-Way Crossover Study
    Shentu, Jianzhong
    Zhou, Huili
    Hu, Xingjiang
    Wu, Guolan
    Wu, Lihua
    Zhu, Meixiang
    Zhai, You
    Zheng, Yunliang
    Liu, Jian
    CLINICAL THERAPEUTICS, 2014, 36 (04) : 579 - 585
  • [25] Relative bioavailability and pharmacokinetics of a new sibutramine formulation in healthy male subjects: A randomized, open-label, two-period, comparative crossover study
    Park, JY
    Kim, KA
    Park, PW
    Suh, KH
    Lee, GS
    CLINICAL THERAPEUTICS, 2004, 26 (12) : 2092 - 2101
  • [26] Bioequivalence and pharmacokinetics of two zidovudine formulations in healthy Brazilian volunteers: An open-label, randomized, single-dose, two-way crossover study
    dos Reis Serra, Cristina Helena
    Mori Koono, Eunice Emiko
    Kano, Eunice Kazue
    Schramm, Simone Grigoleto
    Armando, Yara Popst
    Porta, Valentina
    CLINICAL THERAPEUTICS, 2008, 30 (05) : 902 - 908
  • [27] Bioequivalence of Generic and Branded Subcutaneous Enoxaparin: A Single-Dose, Randomized-Sequence, Open-Label, Two-Period Crossover Study in Healthy Chinese Male Subjects
    Feng, Limin
    Shen-Tu, Jianzhong
    Liu, Jian
    Chen, Junchun
    Wu, Lihua
    Huang, Mingzhu
    CLINICAL THERAPEUTICS, 2009, 31 (07) : 1559 - 1567
  • [28] A randomized, open-label, single-dose, two-cycle crossover study to evaluate the bioequivalence and safety of lenvatinib and Lenvima® in Chinese healthy subjects
    Xu, Zhongnan
    Wang, Yanli
    Liu, Guangwen
    Chen, Jiahui
    Wang, Wanhua
    Cheng, Yang
    Ren, Qing
    Cui, Yingzi
    Yang, Wei
    Liu, Zhengzhi
    Chen, Xuesong
    Xue, Jinling
    Chang, Tianying
    Qu, Xinyao
    Yu, Shuang
    Zhou, Yannan
    Xu, Kaibo
    Su, Zhengjie
    Deng, Qiaohuan
    Zhao, Yicheng
    Yang, Haimiao
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2022, 31 (07) : 737 - 746
  • [29] Bioequivalence Evaluation of Two Capsule Formulations of Amoxicillin in Healthy Adult Male Bangladeshi Volunteers: A Single-Dose, Randomized, Open-Label, Two-Period Crossover Study
    Ullah, Ashik
    Azad, Mohammad Abul Kalam
    Sultana, Rebeka
    Akbor, Maruf Mohammad
    Hasan, Ahasanul
    Latif, Mahbub
    Hasnat, Abul
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2008, 69 (06): : 504 - 513
  • [30] PHASE I, OPEN-LABEL, RANDOMIZED, SINGLE-DOSE STUDY TO ASSESS SAFETY AND PHARMACOKINETICS OF SUBCUTANEOUS ROZIBAFUSP ALFA IN HEALTHY JAPANESE SUBJECTS.
    Abuqayyas, L.
    Cheng, L.
    Simiens, M.
    Dutta, S.
    Houk, B.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 : S53 - S53
12345